Keep Informed on Legal and Compliance Developments Affecting Diagnostic Labs
Best practices and expert insight to help lab professionals comply with regulations and identify strategic trends in business and technology
Already a Subscriber? Log in Here
Lab Industry Advisor Subscription
Keeps you up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
Additional Business Intelligence Offerings
Lab Industry Advisor Subscriptions Include
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
Latest Articles
New FDA LDTs Guidance Offers Useful Summary, But Questions Remain
Recently released document for small labs offers a more digestible version of the final rule requirements but still lacks key details
Agena Bioscience Launches Testing Platform For Non-Small Cell Lung Cancer
By Ron Shinkman, Editor, Laboratory Industry Report San Diego-based Agena Biosciences has released a new testing platform that provides a quick and accurate identification of variations in most non-small cell lung cancers. The platform, known as the LungFusion...
AMP Weighs In on Regulation of Next-Generation Sequencing
By Stephanie Murg, Managing Director, G2 Intelligence As the U.S. Food and Drug Administration (FDA) evaluates its role in regulating next-generation sequencing (NGS)-based diagnostic tests, a range of stakeholders have responded to the agency's request for...
HHS Establishes Another Initiative Promoting Value-Based Reimbursement and Health Care Delivery
By Kelly A. Briganti, Editorial Director, G2 Intelligence The U.S. Department of Health and Human Services (HHS) launched a new resource last week to further the goal of value- and quality-based reimbursement. The Health Care Payment Learning and Action Network...